Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

Leaked no-deal Brexit document forecasts widespread shortages

Leaked no-deal Brexit document forecasts widespread shortages

The report also identified the risks of potential disruptions to the supply of medicines for veterinary use, which the report said ‘would reduce our ability to prevent and control disease outbreaks, ... medicines and medical products tothe country in

Latest news

  • Vertex faces rejection of its CF medicines in Scotland Vertex faces rejection of its CF medicines in Scotland

    Another rejection over cost-effectiveness. The Scottish Medicines Consortium (SMC) has not recommended Vertex’s cystic fibrosis drugs Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) for routine NHS use in Scotland. . ... Even though

  • Still no ferry contracts for no-deal Brexit medicines supplies Still no ferry contracts for no-deal Brexit medicines supplies

    44% of EMIG Members surveyed who stockpiled medicines/medical devices prior to 29 March, have run down or are running down their stockpile. ... 25% of companies have already changed the supply routes they use to import medicines.

  • NICE unveils long-awaited review of methodologies NICE unveils long-awaited review of methodologies

    This will include how it should deal with uncertainty around clinical and cost effectiveness data for new medicines at launch. ... NICE says greater use of ‘data analytics and real-world evidence’ could play a part in how it might revise its

  • Buyers’ Club wants government support on Orkambi imports Buyers’ Club wants government support on Orkambi imports

    compulsory licensing) crown use licence, launch a large scale clinical trial and provide direct support for individuals using the buyers’ club. ... UK regulations allow patients or their parents to import non-UK-registered medicines for personal use,

  • Novo Nordisk targets renewable energy switch by 2030 Novo Nordisk targets renewable energy switch by 2030

    More than 29m people use our medicines and from early next year, they can do so knowing that they're produced using only renewable electricity," said Lars Fruergaard Jørgensen, president and

More from news
Approximately 0 fully matching, plus 255 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    We appreciate that our partnership with the FDA has allowed us to take a significant step forward in the use of real-world data to bring medicines to patients who are ... Real-world data is playing an increasingly important role in expanding the use of

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    over time to health gain relative to expenditure on new medicines across the NHS”. ... What is missing, however, is a reference to the comparisons to other countries on medicines use that was in the 2014 PPRS.

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    It also seems to be relatively efficient, with low admin costs and high use of cheaper generic medicines, and also performs well in managing long-term illnesses, such as diabetes. ... That partnership, it is hoped, will create trust – and some

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    Bucci’s work exemplifies several encouraging trends in healthcare: the development of evidence-based tech for mental health, the use of social enterprise to accelerate progress and the emergence of women ... In 2012 Dr Williams created the GSK Maternal

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    These questions are central to the premise of medicine optimisation: the ‘person-centric approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’. ... This should be the goal of pharma and

More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest appointments

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

  • Marschall Runge joins Lilly’s board of directors Marschall Runge joins Lilly’s board of directors

    Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... His appreciation of the importance of scientific research,

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer

    Targeted therapies for ovarian cancer. In 2011, the European Medicines Agency (EMA) approved the use of targeted therapies, including an anti-angiogenic treatment alongside chemotherapy to increase the effectiveness of treatment ... Zejula. Available at:

  • NHS medicines optimisation milestone

    by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS

  • Patient Engagement and Experience Conference, 16-17 May

    The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .

  • "Legal highs" ruling leaves illegal labs laughing

    There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines

  • Making good practice common practice in rare disease

    Good listeners use a number of techniques - here are two simple examples you can try yourself:. ... Researchers found that the size of the drawing predicted speed of return to work, cardiac anxiety, use of alternative medicines and number of phone calls

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Quick links

Infographics

Multimedia